Prothena Corp Public (PRTA) Prepaid Assets (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly Prepaid Assets came in at $9.7 million in Q1 2026, down 46.6% year-on-year from $18.2 million in Q1 2025, and up 27.11% quarter-over-quarter from $7.7 million in Q4 2025.
Prothena Corp Public (PRTA) Prepaid Assets (2012 - 2026) Analysis & Trends
Prothena Corp Public's Prepaid Assets history runs 15 years deep, the most recent figure standing at $9.7 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 46.6% year-over-year to $9.7 million in Q1 2026; TTM through Mar 2026 was $9.7 million, a 46.6% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, down 45.37% from the prior year.
- Prepaid Assets climbed to $9.7 million in Q1 2026 per PRTA's latest filing, from $7.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $28.9 million in Q3 2022 and bottomed at $7.7 million in Q4 2025.
- The 5-year median for Prepaid Assets is $14.0 million (2024), against an average of $14.6 million.
- Across the five-year window, Prepaid Assets jumped 293.5% in 2022 and tumbled 54.39% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $8.7 million in 2022, then soared by 60.39% to $13.9 million in 2023, then increased by 0.6% to $14.0 million in 2024, then plunged by 45.37% to $7.7 million in 2025, then grew by 27.11% to $9.7 million in 2026.
- Per Business Quant, the three latest PRTA Prepaid Assets figures stand at $9.7 million (Q1 2026), $7.7 million (Q4 2025), and $9.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.74 Mn |
| Dec 31, 2025 | 7.66 Mn |
| Sep 30, 2025 | 9.13 Mn |
| Jun 30, 2025 | 14.04 Mn |
| Mar 31, 2025 | 18.24 Mn |
| Dec 31, 2024 | 14.02 Mn |
| Sep 30, 2024 | 15.72 Mn |
| Jun 30, 2024 | 21.85 Mn |
| Mar 31, 2024 | 18.00 Mn |
| Dec 31, 2023 | 13.94 Mn |
| Sep 30, 2023 | 13.20 Mn |
| Jun 30, 2023 | 16.12 Mn |
| Mar 31, 2023 | 14.16 Mn |
| Dec 31, 2022 | 8.69 Mn |
| Sep 30, 2022 | 28.93 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 12.63 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 7.35 Mn |
| Jun 30, 2021 | 8.28 Mn |